Elevation Oncology, Inc.
ELEV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $24 | $39 | $27 | $18 |
| Gross Profit | -$24 | -$39 | -$27 | -$18 |
| % Margin | – | – | – | – |
| R&D Expenses | $28,597 | $25,434 | $78,717 | $23,595 |
| G&A Expenses | $16,106 | $14,904 | $15,832 | $8,451 |
| SG&A Expenses | $16,106 | $14,904 | $15,832 | $8,451 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $5,107 | $0 | $0 |
| Operating Expenses | $44,703 | $45,445 | $94,549 | $32,046 |
| Operating Income | -$44,703 | -$45,445 | -$94,549 | -$32,046 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $261 | -$229 | -$506 | $7 |
| Pre-Tax Income | -$44,442 | -$45,674 | -$95,055 | -$32,039 |
| Tax Expense | $43 | $30 | $25 | $0 |
| Net Income | -$44,485 | -$45,704 | -$95,080 | -$32,039 |
| % Margin | – | – | – | – |
| EPS | -0.78 | -1.34 | -4.09 | -1.38 |
| % Growth | 41.8% | 67.2% | -196.4% | – |
| EPS Diluted | -0.78 | -1.34 | -4.09 | -1.38 |
| Weighted Avg Shares Out | 57,275 | 34,078 | 23,267 | 23,206 |
| Weighted Avg Shares Out Dil | 57,275 | 34,078 | 23,267 | 23,206 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,200 | $3,900 | $0 | $0 |
| Interest Expense | $3,997 | $4,168 | $479 | $0 |
| Depreciation & Amortization | -$1,464 | $39 | $27 | $18 |
| EBITDA | -$44,703 | -$41,467 | -$94,522 | -$32,028 |
| % Margin | – | – | – | – |